Literature DB >> 18591170

Oncology outpatient and provider responses to a computerized symptom assessment system.

Janet S Carpenter1, Susan Rawl, Jennifer Porter, Karen Schmidt, Jennifer Tornatta, Foluso Ojewole, Paul Helft, David A Potter, Christopher Sweeney, R Brian Giesler.   

Abstract

PURPOSE/
OBJECTIVES: To assess patient and provider responses to a computerized symptom assessment system.
DESIGN: Descriptive, longitudinal study with retrospective, longitudinal medical records review.
SETTING: University-based National Cancer Institute-designated outpatient cancer center. SAMPLE: 80 oncology outpatients receiving chemotherapy, 8 providers, and 30 medical records.
METHODS: Patients completed the computerized assessment during three chemotherapy follow-up clinic appointments (times 1, 2, and 3). Patient usability was recorded via an observer checklist (ease of use) and the computer (completion time). Patient satisfaction and impact were assessed during telephone interviews two to three days after times 1 and 3 only. Provider usability and impact were assessed at the end of the study using a questionnaire and focus groups, whereas effect on provider documentation was assessed through chart audits. MAIN RESEARCH VARIABLES: Patient usability (ease of use, completion time), satisfaction, and impact; provider usability and impact.
FINDINGS: Patients reported good usability, high satisfaction, and modest impact on discussions with their providers. Providers reported modest usability, modest impact on discussions with patients, and had varied reactions as to how the system affected practice. Documentation of symptoms was largely absent before and after implementation.
CONCLUSIONS: This system demonstrated good usability and satisfaction but had only a modest impact on symptom-related discussions and no impact on documentation. IMPLICATIONS FOR NURSING: A computerized system can help address barriers to symptom assessment but may not improve documentation unless it can be integrated into existing medical records systems.

Entities:  

Mesh:

Year:  2008        PMID: 18591170      PMCID: PMC2730523          DOI: 10.1188/08/ONF.661-669

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  28 in total

1.  Internet-based home asthma telemonitoring: can patients handle the technology?

Authors:  J Finkelstein; M R Cabrera; G Hripcsak
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

2.  The concept of symptom cluster.

Authors:  Andrea M Barsevick
Journal:  Semin Oncol Nurs       Date:  2007-05       Impact factor: 2.315

Review 3.  Insomnia in the context of cancer: a review of a neglected problem.

Authors:  J Savard; C M Morin
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating.

Authors:  A S Strömgren; M Groenvold; L Pedersen; A K Olsen; M Spile; P Sjøgren
Journal:  J Pain Symptom Manage       Date:  2001-03       Impact factor: 3.612

5.  Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating.

Authors:  A S Strömgren; M Groenvold; A Sorensen; L Andersen
Journal:  Acta Anaesthesiol Scand       Date:  2001-10       Impact factor: 2.105

6.  A fatigue clinic in a comprehensive cancer center: design and experiences.

Authors:  C P Escalante; T Grover; B A Johnson; M Harle; H Guo; T R Mendoza; E Rivera; V Ho; E L Lee; C S Cleeland
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 7.  Advancing the science of symptom management.

Authors:  M Dodd; S Janson; N Facione; J Faucett; E S Froelicher; J Humphreys; K Lee; C Miaskowski; K Puntillo; S Rankin; D Taylor
Journal:  J Adv Nurs       Date:  2001-03       Impact factor: 3.187

8.  The 'right kind' of pain: talking about symptoms in outpatient oncology consultations.

Authors:  M S Rogers; C J Todd
Journal:  Palliat Med       Date:  2000-07       Impact factor: 4.762

9.  Cancer symptom control: feasibility of a tailored, interactive computerized program for patients.

Authors:  D J Wilkie; H Y Huang; D L Berry; A Schwartz; Y C Lin; N Y Ko; A Chen; J Gralow; S K Lindsley; D Fitzgibbon
Journal:  Fam Community Health       Date:  2001-10

10.  Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum.

Authors:  P Stone; A Richardson; E Ream; A G Smith; D J Kerr; N Kearney
Journal:  Ann Oncol       Date:  2000-08       Impact factor: 32.976

View more
  11 in total

1.  Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.

Authors:  Andrea Barsevick; Susan L Beck; William N Dudley; Bob Wong; Ann M Berger; Kyra Whitmer; Tracey Newhall; Susan Brown; Katie Stewart
Journal:  J Pain Symptom Manage       Date:  2010-06-18       Impact factor: 3.612

Review 2.  Developing effective cancer pain education programs.

Authors:  Michelle Y Martin; Maria Pisu; Elizabeth A Kvale; Shelley A Johns
Journal:  Curr Pain Headache Rep       Date:  2012-08

3.  Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial.

Authors:  Kathi H Mooney; Susan L Beck; Robert H Friedman; Ramesh Farzanfar; Bob Wong
Journal:  Support Care Cancer       Date:  2014-04-01       Impact factor: 3.603

4.  Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

Authors:  Charles S Cleeland; Xin Shelley Wang; Qiuling Shi; Tito R Mendoza; Sherry L Wright; Madonna D Berry; Donna Malveaux; Pankil K Shah; Ibrahima Gning; Wayne L Hofstetter; Joe B Putnam; Ara A Vaporciyan
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

5.  Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial.

Authors:  Donna L Berry; Brent A Blumenstein; Barbara Halpenny; Seth Wolpin; Jesse R Fann; Mary Austin-Seymour; Nigel Bush; Bryant T Karras; William B Lober; Ruth McCorkle
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

6.  Reflections on the implementation of screening for distress (sixth vital sign) in Canada: key lessons learned.

Authors:  Margaret I Fitch; Fred Ashbury; Irene Nicoll
Journal:  Support Care Cancer       Date:  2018-06-01       Impact factor: 3.603

7.  Automated pain intervention for underserved minority women with breast cancer.

Authors:  Karen O Anderson; Guadalupe R Palos; Tito R Mendoza; Charles S Cleeland; Kai-Ping Liao; Michael J Fisch; Araceli Garcia-Gonzalez; Alyssa G Rieber; L Arlene Nazario; Vicente Valero; Karin M Hahn; Cheryl L Person; Richard Payne
Journal:  Cancer       Date:  2015-02-24       Impact factor: 6.860

8.  Communicating advanced cancer patients' symptoms via the Internet: a pooled analysis of two randomized trials examining caregiver preparedness, physical burden, and negative mood.

Authors:  Ming-Yuan Chih; Lori L DuBenske; Robert P Hawkins; Roger L Brown; Susan K Dinauer; James F Cleary; David H Gustafson
Journal:  Palliat Med       Date:  2012-09-17       Impact factor: 4.762

9.  The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.

Authors:  Roma Maguire; Patricia A Fox; Lisa McCann; Christine Miaskowski; Grigorios Kotronoulas; Morven Miller; Eileen Furlong; Emma Ream; Jo Armes; Elisabeth Patiraki; Alexander Gaiger; Geir V Berg; Adrian Flowerday; Peter Donnan; Paul McCrone; Kathi Apostolidis; Jenny Harris; Stylianos Katsaragakis; Alison R Buick; Nora Kearney
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

10.  Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).

Authors:  Lila J Finney Rutten; Kathryn J Ruddy; Linda L Chlan; Joan M Griffin; Jeph Herrin; Aaron L Leppin; Deirdre R Pachman; Jennifer L Ridgeway; Parvez A Rahman; Curtis B Storlie; Patrick M Wilson; Andrea L Cheville
Journal:  Trials       Date:  2020-06-05       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.